Skip to main content

White House withdraws Heidi Overton as FDA commissioner nominee

STAT reports that the White House has withdrawn its nomination of Heidi Overton to lead the US Food and Drug Administration. The FDA commissioner role is central to drug, device and food regulation in the United States.

This development may signal delays or changes in regulatory direction for healthcare and pharmaceutical companies. Senior executives should watch for updates on a new nominee, as leadership changes can affect policy and approval timelines.

Stat

Find out more here